A Sequential Treatment Regimen of Cryotherapy and Picato for the Treatment of Actinic Keratosis on the Face and Scalp.

Trial Profile

A Sequential Treatment Regimen of Cryotherapy and Picato for the Treatment of Actinic Keratosis on the Face and Scalp.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Sep 2016

At a glance

  • Drugs Ingenol mebutate (Primary)
  • Indications Actinic keratosis; Skin cancer
  • Focus Therapeutic Use
  • Acronyms FIELD Study 1
  • Most Recent Events

    • 21 Oct 2013 11 week results are expected to be published by the end of 2013, according to a LEO Pharma media release.
    • 21 Oct 2013 Primary endpoint 'Objective-clinical-response-rate' has been met.
    • 21 Oct 2013 Primary endpoint 'Complete-clinical-response-rate' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top